QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
NYSE:ABBV

AbbVie - ABBV Earnings Date, Estimates & Call Transcripts

$146.28
-1.12 (-0.76%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$146.02
$147.68
50-Day Range
$147.40
$166.55
52-Week Range
$133.05
$175.91
Volume
4.58 million shs
Average Volume
6.09 million shs
Market Capitalization
$258.69 billion
P/E Ratio
19.53
Dividend Yield
4.02%
Price Target
$160.56

Earnings Summary

Upcoming
Earnings Date
Feb. 9Confirmed
Actual EPS
(Oct. 28)
$3.66 Beat By $0.10
Consensus EPS
(Oct. 28)
$3.56
Last Year's Q4 EPS
(10/28/2021)
$3.33
Skip Charts & View Estimated and Actual Earnings Data

ABBV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABBV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AbbVie Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$2.88$3.11$2.98 
Q2 20233$2.88$3.04$2.97 
Q3 20233$2.72$3.11$2.86 
Q4 20233$2.64$3.18$2.86 
FY 202312$11.12$12.44$11.67 
Q1 20241$2.76$2.76$2.76 
Q2 20241$2.85$2.85$2.85 
Q3 20241$2.87$2.87$2.87 

ABBV Earnings Date and Information

AbbVie last posted its earnings results on October 28th, 2022. The reported $3.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.56 by $0.10. The firm earned $14.81 billion during the quarter, compared to analysts' expectations of $14.95 billion. Its revenue was up 3.3% on a year-over-year basis. AbbVie has generated $7.49 earnings per share over the last year ($7.49 diluted earnings per share) and currently has a price-to-earnings ratio of 19.5. Earnings for AbbVie are expected to decrease by -15.98% in the coming year, from $13.89 to $11.67 per share. AbbVie has confirmed that its next quarterly earnings report will be published on Thursday, February 9th, 2023. AbbVie will be holding an earnings conference call on Thursday, February 9th at 9:00 AM Eastern. Interested parties can register for or listen to the call..

AbbVie Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/9/2023
(Confirmed)
 $3.57       
10/28/2022Q3 2022$3.56$3.66+$0.10$5.11$14.95 billion$14.81 billion      
7/29/2022Q2 2022$3.42$3.51+$0.09$6.51$14.64 billion$14.58 billion    
4/29/2022Q1 2022$3.15$3.16+$0.01$3.81$13.61 billion$13.36 billion      
2/2/2022Q4 2021$3.29$3.31+$0.02$4.36$14.96 billion$14.89 billion    
10/28/20219/30/2021$3.22$3.33+$0.11$4.88$14.30 billion$14.34 billion    
7/29/20216/30/2021$3.09$3.11+$0.02$5.80$13.64 billion$13.96 billion      
4/29/20213/31/2021$2.83$2.95+$0.12$3.91$12.84 billion$13.01 billion  
2/2/202112/31/2020$2.85$2.92+$0.07$5.83$13.70 billion$13.86 billion  
10/30/20209/30/2020$2.75$2.83+$0.08$4.37$12.71 billion$12.88 billion    
7/31/20206/30/2020$2.20$2.34+$0.14$5.14$10.14 billion$10.43 billion    
5/1/20203/31/2020$2.25$2.42+$0.17$2.82$8.31 billion$8.62 billion  
2/7/202012/31/2019$2.19$2.21+$0.02$2.54$8.68 billion$8.70 billion  
11/1/2019Q3 2019$2.29$2.33+$0.04$3.40$8.37 billion$8.48 billion    
7/26/2019Q2 2019$2.21$2.26+$0.05$4.03$8.09 billion$8.26 billion  
4/25/2019Q1 2019$2.06$2.14+$0.08$2.63$7.81 billion$7.83 billion  
1/25/201912/31/2018$1.92$1.90($0.02)$5.03$8.37 billion$8.31 billion  
11/2/20189/30/2018$2.01$2.14+$0.13$2.47$8.23 billion$8.24 billion  
7/27/20186/30/2018$1.98$2.00+$0.02$2.74$8.22 billion$8.28 billion
4/26/2018Q1 2018$1.79$1.87+$0.08$2.00$7.60 billion$7.93 billion
1/26/2018Q4 2017$1.44$1.48+$0.04$2.93$7.53 billion$7.74 billion  
10/27/2017Q3 2017$1.39$1.41+$0.02$1.81$7.00 billion$7.00 billion
7/28/2017Q2 2017$1.40$1.42+$0.02$1.65$6.93 billion$6.94 billion
4/27/2017Q1 2017$1.2620$1.28+$0.0180$1.50$6.49 billion$6.54 billion
1/27/2017Q416$1.20$1.20$1.55$6.92 billion$6.78 billion  
10/28/2016Q316$1.21$1.21$1.45$6.55 billion$6.43 billion  
7/29/2016Q216$1.20$1.26+$0.06$1.54$6.20 billion$6.43 billion  
4/28/2016Q116$1.14$1.15+$0.01$1.47$6.03 billion$5.96 billion  
1/29/2016Q415$1.12$1.13+$0.01$1.34$6.41 billion$6.36 billion  
10/30/2015Q315$1.08$1.13+$0.05$1.52$5.90 billion$4.94 billion  
7/24/2015Q215$1.06$1.08+$0.02$1.33$5.60 billion$5.48 billion  
4/23/2015Q115$0.85$0.94+$0.09$1.25$718.50 million$5.04 billion  
1/30/2015Q414$0.86$0.89+$0.03$2.29$5.34 billion$5.45 billion  
10/31/2014Q3$0.77$0.89+$0.12$1.47$4.82 million$5.02 million  
7/25/2014Q214$0.76$0.82+$0.06$0.96$4.70 billion$4.93 billion  
4/25/2014Q114$0.68$0.71+$0.03$0.83$4.33 billion$4.56 billion  
1/31/2014Q4 2013$0.83$0.82($0.01)$0.94$5.10 billion$5.11 billion  
10/25/2013Q3 2013$0.78$0.82+$0.04$1.04$4.52 billion$4.66 billion  
7/26/2013Q2 2013$0.79$0.82+$0.03$0.98$4.54 billion$4.69 billion  
4/26/2013Q1 2013$0.66$0.68+$0.02$0.76$4.17 billion$4.33 billion  












AbbVie Earnings - Frequently Asked Questions

When is AbbVie's earnings date?

AbbVie has confirmed that its next quarterly earnings data will be published on Thursday, February 9th, 2023. Learn more on ABBV's earnings history.

Did AbbVie beat their earnings estimates last quarter?

In the previous quarter, AbbVie (NYSE:ABBV) reported $3.66 earnings per share (EPS) to beat the analysts' consensus estimate of $3.56 by $0.10. Learn more on analysts' earnings estimate vs. ABBV's actual earnings.

How can I listen to AbbVie's earnings conference call?

The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call

How can I read AbbVie's conference call transcript?

The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript

How can I view AbbVie's earnings report?

AbbVie's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does AbbVie generate each year?

AbbVie (NYSE:ABBV) has a recorded annual revenue of $56.20 billion.

How much profit does AbbVie generate each year?

AbbVie (NYSE:ABBV) has a recorded net income of $11.54 billion. ABBV has generated $7.49 earnings per share over the last four quarters.

What is AbbVie's price-to-earnings ratio?

AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 19.53 and a forward price-to-earnings ratio of 10.53. The price/earnings-to-growth ratio is 3.16.

What is AbbVie's EPS forecast for next year?

AbbVie's earnings are expected to decrease from $13.89 per share to $11.67 per share in the next year, which is a -15.98% change.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:ABBV) was last updated on 1/27/2023 by MarketBeat.com Staff